Potnick; Justin

Patent Applications and Registrations

Patent applications and USPTO patent grants for Potnick; Justin.The latest application filed is for "heteroaryl compounds as btk inhibitors and uses thereof".

Company Profile

3.14.14

Potnick; Justin - Acton MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Heteroaryl compounds as BTK inhibitors and uses thereof Grant 11,098,041 - Gaillard , et al. August 24, 2	2021-08-24
Heteroaryl Compounds As Btk Inhibitors And Uses Thereof App 20190233417 - Gaillard; Pascale ; et al.	2019-08-01
Heteroaryl compounds as BTK inhibitors and uses thereof Grant 10,253,023 - Gaillard , et al.	2019-04-09
Substituted pyrido[3,4-d]pyrimidines and pyrido[4,3-d]pyrimidines as p70S6K inhibitors Grant 10,233,160 - Huck , et al.	2019-03-19
Heterocyclic carboxamides as modulators of kinase activity Grant 10,080,753 - Huck , et al. September 25, 2	2018-09-25
Positive allosteric modulators of mGluR3 Grant 10,059,671 - Potnick August 28, 2	2018-08-28
Azaquinazoline Carboxamide Derivatives App 20180237402 - HUCK; Bayard R. ; et al.	2018-08-23
Substituted benzo[d][1,2,3]triazines as p70S6K inhibitors Grant 9,981,925 - Huck , et al. May 29, 2	2018-05-29
Substituted acetylene derivatives and their use as positive allosteric modulators of mGluR4 Grant 9,879,004 - Richardson , et al. January 30, 2	2018-01-30
Spiro-quinazolinone derivatives and their use as positive allosteric modulators of mGluR4 Grant 9,708,321 - Brugger , et al. July 18, 2	2017-07-18
Azaquinazoline Carboxamide Derivatives App 20160340323 - HUCK; Bayard R. ; et al.	2016-11-24
Novel Heterocyclic Carboxamides As Modulators Of Kinase Activity App 20160339028 - HUCK; Bayard R. ; et al.	2016-11-24
Substituted pyrido[3,2-d]pyrimidines for treating cancer Grant 9,440,968 - Huck , et al. September 13, 2	2016-09-13
Heteroaryl Compounds As Btk Inhibitors And Uses Thereof App 20160096834 - GAILLARD; Pascale ; et al.	2016-04-07
Novel Heterocyclic Carboxamides As Modulators Of Kinase Activity App 20160058763 - HUCK; Bayard R. ; et al.	2016-03-03
Substituted Acetylene Derivatives and their Use as Positive Allosteric Modulators of mGluR4 App 20150376182 - RICHARDSON; Thomas E. ; et al.	2015-12-31
Positive Allosteric Modulators Of Mglur3 App 20150361046 - POTNICK; Justin	2015-12-17
Spiro-Quinazolinone Derivatives and their Use as Positive Allosteric Modulators of mGluR4 App 20150361079 - BRUGGER; Nadia ; et al.	2015-12-17
Heterocyclic carboxamides as modulators of kinase activity Grant 9,139,568 - Huck , et al. September 22, 2	2015-09-22
Azaquinazoline Carboxamide Derivatives App 20150259339 - Huck; Bayard R. ; et al.	2015-09-17
Azaheterocyclic compounds Grant 9,023,847 - Sutton , et al. May 5, 2	2015-05-05
Furopyridine derivatives Grant 9,006,440 - Burgdorf , et al. April 14, 2	2015-04-14
Novel Heterocyclic Carboxamides as Modulators of Kinase Activity App 20140309245 - Huck; Bayard R. ; et al.	2014-10-16
Furopyridine Derivatives App 20130225569 - Burgdorf; Lars ; et al.	2013-08-29
Novel Azaheterocyclic Compounds App 20120277228 - Sutton; Amanda E. ; et al.	2012-11-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.